Simvastatin 40 mg
Sponsors
Organon and Co, University of Illinois at Chicago, University of Ioannina, Abbott, Thammasat University
Conditions
Aneurysmal Subarachnoid HemorrhageCerebral VasospasmCoronary DiseaseDyslipidemiaHypercholesterolemiaIschemic Stroke
Phase 3
A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease
CompletedNCT01674712
Start: 2012-06-30End: 2013-10-31Updated: 2014-12-11
Efficacy of High and Low-Dose Simvastatin on Vascular Oxidative Stress and Neurological Outcome in Patients With AIS
CompletedNCT03402204
Start: 2014-04-01End: 2015-12-31Updated: 2020-08-11
Phase 4
The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED)
CompletedNCT00423579
Start: 2006-07-01End: 2008-03-01Updated: 2024-05-22
Comparison of Simvastatin Versus Simvastatin/Ezetimibe on Small Dense Low -Density Lipoprotein (LDL)
CompletedNCT00932620
Start: 2009-06-30End: 2010-04-30Updated: 2011-08-19